Astorne Capital

Astorne Capital, which last reported a 1.55 percent stake in Innovision Limited, is no longer listed among the company's named shareholders, indicating either a complete exit or a reduction to below the 1 percent disclosure threshold.

Astorne Capital decreased its stake in Alpex Solar from 1.22% to 1.17% by selling 11,000 shares. The value of the shares sold is ₹94.22 lakh, calculated at a share price of ₹856.55.

Astorne Capital, which previously held a 1.15 percent stake in Sai Parenterals Limited, is no longer listed among its public shareholders, indicating either a complete sale or a reduction to below the 1 percent reporting threshold.

Astorne Capital increased its stake in Arisinfra Solutions by purchasing 1,93,241 shares, raising its holding from 1.21% to 1.44%. The shares were valued at approximately ₹2.13 Cr, at a price of ₹110.39 per share.

Astorne Capital increased its stake in Senores Pharmaceuticals from 1.53% (705,346 shares) to 1.95% (897,350 shares), acquiring an additional 192,004 shares. The value of its increased holding is ₹12.93 Cr based on Senores Pharmaceuticals' share price of ₹1405.10.

Astorne Capital increased its stake in PNGS Reva Diamond Jewellery from 1.89% to 2.87% through a rights issue, acquiring 309,016 shares valued at ₹12.3 Cr at the current share price.

Astorne Capital decreased its stake in Ratnaveer Precision Engineering Limited from 3.90% to 1.47% by selling 16 lakh shares. The value of the shares sold is ₹28.9 crore at ₹180.66 apiece.

Astorne Capital reduced its stake in Agi Infra Limited from 2.89% to 2.71%, selling 225,000 shares. This transaction is valued at ₹7.86 crore, with shares priced at ₹349.20 apiece.

Astorne Capital bought 15 lakh shares of Shanti Gold International for ₹33.75 Cr at ₹225.00 apiece in a bulk deal. The share price of Shanti Gold International closed at ₹221.84 on the trade date.